With the global spread of novel Coronavirus (COVID-19), FEG has made the decision to postpone the FEG 2020 Investment Symposium.
The information provided below will change. We will communicate an updated schedule and agenda once we know more in the coming weeks.
Thank you for your patience and understanding during this unprecedented time. Please contact us with any questions or concerns.
|9:30 a.m.–12:00 p.m.||Symposium Check-In|
|11:00 a.m.–11:10 a.m.||FEG Welcome|
|11:10 a.m.–12:00 p.m.||Joshua Friedman, Canyon Partners|
|12:00 p.m.–1:00 p.m.||Networking Lunch|
|1:00 p.m.–1:50 p.m.||Biotech Panel|
|2:00 p.m.–2:50 p.m.||Death in the Oil Patch|
|2:50 p.m.–3:15 p.m.||Afternoon Coffee Break|
|3:15 p.m.–4:05 p.m.||Keynote Session|
|4:05 p.m.–4:15 p.m.||FEG Closing|
|4:15 p.m.–6:30 p.m.||Cocktail hour on the Rooftop Terrace|
The dress code is business casual. Conference agenda items and times are subject to change.
We are excited to have John Baschab as a panelist on the Real Assets panel. He is a co-founder, manager of the General Partner and member of the investment committee at Scout. He is responsible for capital raising, investor relations, information technology, commodity product marketing and commodity product hedging.
John Baschab is co-founder, manager of the General Partner and member of the investment committee at Scout. Scout is a private energy investment manager established in 2011 in Dallas Texas. The Scout strategy focuses on acquiring and operating mature producing assets in the contiguous United States. Scout has completed 52 acquisitions and operates in five states producing over 100,000 gross boepd. The firm currently has $2.25 billion in assets under management across five funds for 48 institutional partners.
John earned a BS from the University of Alabama and MBA from the University of Chicago Booth School of Business. He was an adjunct professor at Southern Methodist University from 2003 to 2010 and is co-author of four books published by John Wiley & Sons, including Outperform: Inside the Investment Strategy of Billion Dollar Endowments (2010).
Joshua spoke in 2013 at the FEG Investment Forum. We are proud to have him return and be this year's opening keynote speaker. He is Co-Founder, Co-Chairman and Co-Chief Executive Officer of Canyon Partners, LLC, a leading global alternative asset management firm headquartered in Los Angeles, California.
Joshua S. Friedman is Co-Founder, Co-Chairman and Co-Chief Executive Officer of Canyon Partners, LLC, a leading global alternative asset management firm headquartered in Los Angeles, California. Canyon specializes in value-oriented investments for endowments, foundations, pension funds, sovereign wealth funds and other institutional investors. Its investment strategies focus on distressed loans, corporate bonds, convertible bonds, securitized assets, direct investments, real estate, arbitrage, and value equities. Canyon Partners’ flagship fund, the Canyon Value Realization Fund, twice received Institutional Investor’s “Credit-Focused Hedge Fund Manager of the Year” Award. Additionally, the Canyon Structured Asset Fund received Institutional Investor’s “Hybrid Hedge Fund of the Year” Award. Mr. Friedman has also received Institutional Investor’s “Lifetime Achievement” Award.
Mr. Friedman is a graduate of Harvard College (1976) (B.A., summa cum laude, Phi Beta Kappa, Physics), Oxford University (1978) (M.A., honors, Politics and Economics, Marshall Scholar), Harvard Business School (1980) (M.B.A., Baker Scholar) and Harvard Law School (1982) (J.D., Sears Prize, magna cum laude). Prior to forming Canyon, Mr. Friedman was Director of Capital Markets for High Yield and Private Placements at Drexel Burnham Lambert. Prior to working at Drexel, he worked in the Mergers and Acquisitions Department of Goldman Sachs in New York.
Mr. Friedman is a member of the Board of Directors of Harvard Management Company. He is also a member of Harvard’s Committee on University Resources; the Harvard Business School Board of Dean’s Advisors; the Harvard University Campaign Executive Committee; and the Harvard University Task Force on Science and Engineering. Mr. Friedman serves as a Trustee for The Andrew W. Mellon Foundation; the California Institute of Technology (Caltech); Lincoln Center for the Performing Arts; the Los Angeles Philharmonic; and the Los Angeles County Museum of Art (LACMA). Mr. Friedman is a member of the Investment Committees for The Andrew W. Mellon Foundation, the Broad Foundation, and the J. Paul Getty Trust and chair of the LACMA Finance Committee. He is a member of the Executive Committees for the Los Angeles County Museum of Art (LACMA) and the California Institute of Technology (Caltech). Mr. Friedman also serves on the Boards of Advisors of the UCLA Hospital Department of Neurosurgery and the UCLA Anderson School of Management.
Mr. Friedman is a former chair of the Investment Committee of the Board of Trustees of Caltech (2013-2019).
Mr. Friedman and his wife, Beth, live in Los Angeles and have three sons. Mr. and Mrs. Friedman are 2019 recipients of the Ellis Island Medal of Honor.
Peter will be on our Biotech panel. He is a founder and Managing Partner at RA Capital Management. Peter is active in both public and private investments in companies developing drugs, medical devices, diagnostics, and research tools and serves as a Board Member for various publicly- and privately-held companies.
Peter Kolchinsky is a founder and Managing Partner at RA Capital Management. Peter is active in both public and private investments in companies developing drugs, medical devices, diagnostics, and research tools and serves as a Board Member for various publicly- and privately-held companies. Peter also leads the firm’s engagement and publishing efforts, which aim to make a positive social impact and spark collaboration among healthcare stakeholders, including patients, physicians, researchers, policymakers, and industry. He served on the Board of Global Science and Technology for the National Academy of Sciences, is the author of "The Great American Drug Deal" and "The Entrepreneur’s Guide to a Biotech Startup", and frequently writes and speaks on the future of biotechnology innovation. Peter holds a BA from Cornell University and a PhD in Virology from Harvard University.
Kush M Parmar, M.D., Ph.D. is a Managing Partner at 5AM Ventures. Dr. Parmar serves as a Director on the Boards of Akouos, Entrada, Homology (NASDAQ: FIXX), Rally Bio and Vor Biopharma. He previously served as Acting VP of Strategy and Corporate Development at Novira (acquired by J&J) and served as Board Member or Observer for Achaogen (NASDAQ: AKAO), Arvinas (NASDAQ: ARVN), Audentes (NASDAQ: BOLD), Envoy (acquired by Takeda) and scPharmaceuticals (NASDAQ: SCPH). Dr. Parmar serves on the Advisory Boards of Penn Medicine, Princeton University’s Department of Molecular Biology, and the Grace Science Foundation. He is a Fellow of the Society of Kauffman Fellows. Prior to 5AM, Dr. Parmar was at Harvard Medical School, where he was an NIH-sponsored M.D./Ph.D. Physician Scientist Fellow in the Harvard-MIT Health Sciences and Technology Program. He completed clinical clerkships at the Massachusetts General & Brigham and Women’s Hospitals. At Princeton University, Dr. Parmar worked on developmental genetics with Eric F. Wieschaus (Nobel Prize in Medicine in 1995). He holds an A.B. in Molecular Biology and Medieval Studies from Princeton University, a Ph.D. in Experimental Pathology from Harvard University and an M.D. from Harvard Medical School. Dr. Parmar is based in the Boston, MA office.
William J. Quinn is the founder and Managing Partner of Pearl Energy Investments. Prior to founding Pearl, Billy served as Managing Partner of Natural Gas Partners (NGP). In his capacity as Managing Partner, he co-managed NGP’s investment portfolio and played an active role in the full range of NGP’s investment process, from transaction sourcing through analysis, execution, and exit. Billy was also a key element in the firm’s business development activities given his extensive industry contacts in the U.S. and Canada.
Billy gained valuable investment experience working for Rainwater, Inc. and Hicks, Muse, Tate and Furst, Inc. He also worked as an analyst in the investment banking divisions of Bear Stearns & Co. and BT Securities Corporation.
In addition to his investing activities, Billy serves as a guest lecturer on private equity investing at Stanford University’s Graduate School of Business and the Wharton School of the University of Pennsylvania. He also sits on the Wharton School Board of Overseers.
Billy received a B.S.E. in Finance, with honors, from the Wharton School of the University of Pennsylvania, and an M.B.A. from the Stanford University Graduate School of Business.